Inhibition of Nox2 Oxidase Activity Ameliorates Influenza A Virus-Induced Lung Inflammation
Author Information
Author(s): Vlahos Ross, Stambas John, Bozinovski Steven, Broughton Brad R. S., Drummond Grant R., Selemidis Stavros
Primary Institution: Department of Pharmacology, The University of Melbourne
Hypothesis
Is Nox2-containing NADPH oxidase a novel pharmacological target against lung inflammation caused by influenza A viruses?
Conclusion
Nox2 inhibitors have therapeutic potential for controlling lung inflammation and damage in an influenza strain-independent manner.
Supporting Evidence
- Nox2−/y mice showed reduced lung inflammation and viral titers compared to WT mice.
- In vivo administration of the Nox2 inhibitor apocynin significantly suppressed viral titer and airways inflammation.
- Nox2 inhibitors could be considered for controlling lung inflammation caused by influenza A viruses.
Takeaway
This study shows that blocking a specific enzyme can help reduce lung damage caused by the flu virus, making it easier for the body to fight off the infection.
Methodology
Male WT and Nox2−/y mice were infected with influenza A virus, and various parameters including viral titer and lung inflammation were assessed.
Participant Demographics
Male C57BL/6 (wild type) and Nox2 deficient (Nox2−/y) mice aged between 7 and 10 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website